AbbVie Inc. (ABBV) is listed on NYSE in the Healthcare sector Β· Drug Manufacturers - General industry. The current price is 260.89, down -0.32% from the previous close. Market cap is approximately $461B.
The commentary below is auto-generated by comparing market data (P/E, ROE, D/E, etc.) against predefined thresholds. No LLM is used. This is not a buy/sell recommendation from us or any analyst. For reference only.
A P/E of 73.91x reflects strong expectations for future earnings growth. Multiple compression often starts the first quarter growth decelerates.
Revenue is growing 10.20% year-over-year. Double-digit growth often reflects share gains or new-market entry.
AbbVie Inc.'s 2.64% yield is standard. If the company is also buying back stock, evaluate on total shareholder return (dividends + buybacks) rather than yield alone.
Clinical trial outcomes, FDA decisions, and drug-pricing policy drive most of the short-term volatility.
AbbVie Inc. is near its 52-week high (267.47), in the top 9% of the range. Prices close to new highs invite two readings β little overhead supply, or stretched expectations β and volume is the usual tiebreaker.
The stock moved within a 2.77% high-to-low band on the day, closing -0.32%. That falls within a typical intraday range.
AbbVie Inc. (ABBV) is listed on NYSE, with recent volume of 911,673 shares. Volume is a supporting gauge of how much conviction sits behind a price move β the same gain reads differently on heavy versus light turnover.
AbbVie Inc. has 1 recorded picks from AI discovery and early signals since 2026-08-29. Each entry was written the moment the pick was made and has never been edited or deleted.
No pick has completed its 20-trading-day evaluation yet.
| Date | Source | 5d alpha | 20d alpha |
|---|---|---|---|
| 2026-08-29 | Early Signal | Pending | Pending |
A pick is not a recommendation to buy or sell, and past results do not guarantee future returns. Alpha is the excess return in percentage points after subtracting the benchmark index over the same period.
Your watchlist and portfolio, one tap from your home screen β the Margin Call app